# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-26-155058
Filing Date
2026-04-14
Accepted
2026-04-14 17:00:16
Documents
19
Period of Report
2026-05-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | rgnx-20260414.htm iXBRL | DEF 14A | 1320142
2 | GRAPHIC | img243527914_0.jpg | GRAPHIC | 19663
3 | GRAPHIC | img243527914_1.jpg | GRAPHIC | 32056
4 | GRAPHIC | img243527914_2.jpg | GRAPHIC | 26460
5 | GRAPHIC | img243527914_3.gif | GRAPHIC | 155786
6 | GRAPHIC | img243527914_4.gif | GRAPHIC | 168928
7 | GRAPHIC | img243527914_5.jpg | GRAPHIC | 479187
8 | GRAPHIC | img243527914_6.jpg | GRAPHIC | 205600
| Complete submission text file | 0001193125-26-155058.txt |  | 4603334

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | rgnx-20260414.xsd | EX-101.SCH | 26449
22 | EXTRACTED XBRL INSTANCE DOCUMENT | rgnx-20260414_htm.xml | XML | 124955

Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37553 | Film No.: 26861499
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)